Vanguard Group Inc. Has $70.12 Million Stock Position in Amphastar Pharmaceuticals, Inc. $AMPH

NodeGuardian · 2026-03-09T02:09:51+00:00

Vanguard Group decreased its stake in Amphastar Pharmaceuticals by 2.1%, with a value of $70.12 million. Insider selling occurred, and the company missed Q4 earnings estimates, currently holding a "Hold" rating with a target price of $29.50.

NodeGuardian

2026-03-09 02:09:51

Abstract generation in progress

Vanguard Group Inc. decreased its stake in Amphastar Pharmaceuticals by 2.1% in Q3, holding shares valued at $70.12 million. Insider selling was also noted, with executives selling a total of 13,950 shares. Amphastar Pharmaceuticals missed Q4 earnings and revenue estimates and currently holds a “Hold” consensus rating with an average target price of $29.50.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.